Welcome to our dedicated page for Clarivate news (Ticker: CLVT), a resource for investors and traders seeking the latest updates and insights on Clarivate stock.
Clarivate Plc reports developments in data, analytics and workflow software for academia and government, intellectual property, and life sciences and healthcare. Its news commonly covers earnings, subscription and recurring revenue trends, cash flow and leverage actions, and progress under its operating improvement initiatives.
Company updates also focus on AI-enabled research and decision-support products, including Web of Science Research Intelligence, Nexus Connect, Cortellis Regulatory Intelligence, Derwent-based patent analytics and other Clarivate data assets. Recurring announcements address institutional research intelligence, academic library workflows, regulatory intelligence for life sciences teams, intellectual property benchmarks and investor conference appearances.
Clarivate (NYSE: CLVT) announced that Nissan Motor Co. (7201.T) has selected IPfolio, Clarivate's intellectual property management software, to modernize Nissan's IP operations.
The implementation will provide advanced workflow automation, customized workflows, improved data visibility, and API integration to enable scalable IP management, better portfolio control, and enhanced protection of intellectual property.
Clarivate (NYSE:CLVT) on December 4, 2025 launched the Cortellis Regulatory Intelligence AI Assistant, an agentic AI tool now available to all Cortellis Regulatory Intelligence customers.
The assistant provides instant, cited, context-aware answers; multilingual support; rapid document summarization; and draft-versus-final guidance comparison to speed regulatory review and decision making. Developed with customer feedback and built on Clarivate's existing AI platform, the product targets life sciences regulatory teams and aims to improve accuracy and workflow efficiency across the product lifecycle.
Clarivate (NYSE: CLVT) launched Derwent Patent Monitor on November 24, 2025 to streamline IP and R&D patent reviews and accelerate decisions on patentability, freedom to operate (FTO), opposition and assertion.
The cloud solution uses AI-powered threat analysis built on proprietary Derwent World Patents Index data — including 67m+ invention summaries authored by 850+ Clarivate experts — to surface critical risks and speed first-pass reviews. The product is purpose-built for collaboration with structured project reviews and real-time feedback to reduce reliance on scattered emails and spreadsheets and help patent teams align more quickly.
Clarivate (NYSE: CLVT) said CEO Matt Shem Tov and EVP/CFO Jonathan Collins will present at the RBC Capital Markets Global Technology, Internet, Media and Telecommunications Conference on Wednesday, November 19, 2025 at 1:20 pm ET.
The presentation will be live-webcast at https://kvgo.com/rbc-2025-global-tech/clarivate-november-2025, with a replay available on the company investor site https://ir.clarivate.com for 90 days after the event.
Clarivate (NYSE: CLVT) released its Companies to Watch: Rediscovering Women's Health report on November 13, 2025, spotlighting seven startups advancing therapies and research across reproductive care, chronic disease and mental health.
The report cites persistent underinvestment—women's health receives 15% of venture capital and 5% of global healthcare R&D funding—and highlights clinical-stage programs and financing momentum for named companies including Daré Bioscience, Freya Biosciences, Gesynta Pharma, Granata Bio, Hope Medicine, Oxolife and Reunion Neurosciences.
Methodology relied on Clarivate proprietary sources (Cortellis deals, clinical, regulatory and competitive intelligence) to assess proof of concept, milestones, collaborations, capital raised and intellectual property.
Clarivate (NYSE:CLVT) released the Highly Cited Researchers 2025 list on November 12, 2025, recognizing 6,868 individuals with 7,131 awards from 1,300+ institutions in 60 countries.
Key metrics: the U.S. leads with 2,670 awards (37%); Mainland China second with 1,406 awards (20%); Chinese Academy of Sciences tops institutions with 258 awards. The program added scrutiny in 2025 and excluded 432 potential awards for hyper-prolific publication; Mathematics was reintroduced.
Clarivate (NYSE: CLVT) announced on November 6, 2025 that FUJIFILM Holdings selected IPfolio, Clarivate's cloud-based IP management platform, to consolidate and manage Fujifilm's intellectual property across its healthcare, electronics, business innovation and imaging businesses.
IPfolio will provide a single workflow platform for the IP lifecycle, enable faster IP decision-making, improve measurement of IP activities, and integrate with internal and external systems to support Fujifilm's AI/DX-era IP transformation and corporate value goals.
Clarivate (NYSE:CLVT) released the Pulse of the Library 2025 report on October 30, 2025, based on 2,032 responses across 109 countries. The survey finds 67% of libraries exploring or implementing AI (up from 63% in 2024) and links higher AI literacy, formal training (28%), dedicated time/resources (23.3%) and manager encouragement (24.2%) to stronger implementation and confidence. Regional gaps are notable: Asia and Europe show larger implementation gains (37–40% in initial implementation or beyond) while the U.S. reports only 7% optimism about AI benefits. Budget pressures persist, with ~50% of U.S./North American respondents expecting collections cuts.
Clarivate (NYSE: CLVT) reported third-quarter 2025 results for the period ended September 30, 2025, showing stable revenue and improved cash returns.
Total Q3 revenue was $623.1M (up 0.1% YoY). Organic ACV grew 1.6% year-over-year and the recurring-revenue mix improved 800 basis points to 88% through nine months. Q3 net loss narrowed to $28.3M (−$0.04/share) versus −$65.6M a year earlier; adjusted EBITDA was $252.4M (down 4.5% YoY).
Through nine months Clarivate generated $468.6M operating cash flow and $276.1M free cash flow, repurchased ~34.8M shares (~$150M) including 11.7M in Q3, and repaid $100M of debt. The company raised full-year 2025 revenue guidance to $2.42B–$2.45B.
Clarivate (NYSE: CLVT) announced that Winbond selected and implemented Clarivate's cloud-based IP management platform IPfolio on October 7, 2025.
The implementation delivered concrete results: a 90% improvement in data accuracy via integration with Clarivate IP data, a 25% increase in internal operational efficiency, and an estimated 15% reduction in management time through automation, real-time reporting, email document archiving, and partner collaboration. The rollout also increased the frequency of real-time patent data updates and functions as a virtual IP administrator for Winbond.